GLP-1 Receptor Agonist Use and Risk of Suicide Death
This cohort study assesses the association between use of glucagon-like peptide-1 receptor agonists and the risk of suicide death in routine clinical practice.
Related Articles
Measles cases rose 20% worldwide in 2023, per new report
Measles cases rose 20% worldwide in 2023 compared to the previous year, and vaccination rates still haven’t recovered to pre-pandemic levels.
Child abuse, neglect, and exploitation of young people
Standardising practice can improve identification and reduce bias Even for the most experienced healthcare providers, recognising and evaluating suspected child maltreatment or exploitation is challenging.…
Jay Bhattacharya, an NIH critic, emerges as a top candidate to lead the agency
The Stanford physician was excoriated by NIH’s director in 2020 for his “fringe” ideas on covid. Four years later, he’s poised for power in Trump’s…
Cumberland councillor urges men to test for prostate cancer
Brian Wernham says he first discovered he may have the disease after buying an online test.
DS3 Bandwidth – Best Network Solution at the Best Possible Price in Your Area!
FREE Help With Sourcing & Designing Your Network Infrastructure Compare 100s Of Providers On Cost, Quality, Service, Reliability, & Capability Delivering Customized Solutions & Strategies…
Jonathan Stine, MD: Exercise’s Benefit in MASH is Independent of Weight Loss
Stine reviews findings from a posthoc analysis of the NASHFit trial suggesting the impact of exercise on MASH resolution, even without weight loss.
Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression
TUESDAY, Nov. 12, 2024 (HealthDay News) — Beta blockers are go-to meds for many people who’ve survived a heart attack.However, new Swedish research has found…
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
Existing policies have failed to address overweight and obesity. Without major reform, the forecasted trends will be devastating at the individual and population level, and…
Regulatory Fate of Cancer Indications in the EU After Accelerated Approval in the US
This cohort study investigates the regulatory fate in the European Union for drugs that received accelerated approval for cancer indications in the US.
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention
This Viewpoint describes what dermatologists should know about doxycycline postexposure prophylaxis (doxyPEP) for bacterial sexually transmitted infection (STI) prevention, specifically syphilis, chlamydia, and gonorrhea.
